US 7354580
Method of administering and using VEGF inhibitors for the treatment of human cancer
granted A61KA61K38/00A61K38/17
Quick answer
US patent 7354580 (Method of administering and using VEGF inhibitors for the treatment of human cancer) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/00, A61K38/17, A61K45/06, A61P